As the Covid-19 pandemic continues to evolve in a complex manner, threatening the lives and health of people around the world, research and testing of vaccines and treatments is taking place at an unprecedented pace. One of the potential treatments is the antiviral drug remdesivir. The results of two phase 3 clinical trials of this drug have just been published in the prestigious medical journal The New England Journal of Medicine.